<- Go Home
Novartis India Limited
Novartis India Limited is involved in the pharmaceutical business in India. The company offers therapeutic products in the areas of bone and pain products under the Voveran brand; transplantation immunology products under the Simulect, Certican, Sandimmun, Neoral, and Myfortic brands. It also offers neuroscience products under the Tegrital and Exelon brands. Novartis India Limited was incorporated in 1947 and is headquartered in Mumbai, India. Novartis India Limited operates as a subsidiary of Novartis AG.
Market Cap
INR 32.6B
Volume
15.9K
Cash and Equivalents
INR 6.7B
EBITDA
INR 941.0M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
INR 1.6B
Profit Margin
44.02%
52 Week High
INR 1.6K
52 Week Low
INR 750.00
Dividend
N/A
Price / Book Value
3.99
Price / Earnings
35.01
Price / Tangible Book Value
3.99
Enterprise Value
INR 26.0B
Enterprise Value / EBITDA
27.61
Operating Income
INR 921.5M
Return on Equity
11.63%
Return on Assets
5.98
Cash and Short Term Investments
INR 6.7B
Debt
INR 32.1M
Equity
INR 8.2B
Revenue
INR 3.5B
Unlevered FCF
INR 708.0M
Sector
Pharmaceuticals
Category
N/A